# K162565: VIA 17 Microcatheter

- Pathway: 510(k) (Traditional)
- Applicant: Sequent Medical, Inc.
- Decided: Feb 18, 2017 after 157 days
- Product code: DQY (Catheter, Percutaneous)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K960806 (1996). 25 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 27 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K150894: VIA 21 Microcatheter, Sequent Medical, Inc. (2015) Summary page 4.
- K132652: Via Microcatheter, Via Plus Microcatheter, Sequent Medical, Inc. (2013) Summary page 4.
- K101542: Headway 17 Advanced Microcatheter, MicroVention, Inc. (2010) Summary page 4.

## Most influential descendants
- K192135: VIA Microcatheter (size 17), VIA Microcatheter (size 21), VIA Microcatheter (size 27), VIA Microcatheter (size 33) (2019), 0 descendants of its own

## Indications for use
The VIA™ 17 Microcatheter is intended for the introduction of non-liquid interventional devices (such as coils/stents) and infusion of diagnostic agents (such as contrast media) into the neuro, peripheral and coronary vasculature.

Source page: https://510kreport.com/device/K162565
Methodology: https://510kreport.com/methodology